Your Cart
Loading

The Complete Diabetes & GLP-1 Clinical Bundle - 2 Practical Medical Books | 2026/2027

On Sale
$12.00
$12.00
Added to cart

πŸ“š THE ULTIMATE DIABETES & GLP-1 CLINICAL MASTERCLASS BUNDLE

2026–2027 | Expanded Edition

TWO COMPREHENSIVE MEDICAL eBOOKS | APPROXIMATELY 312 PAGES | ONE COMPLETE CLINICAL LEARNING EXPERIENCE!

πŸ“˜ THE COMPLETE CLINICAL DIABETES CASEBOOK β€” 2026–2027 Expanded Edition

269 Pages | 61 Clinical Cases | 12 Comprehensive Sections

πŸ“— THE COMPLETE PRACTICAL GUIDE TO GLP-1 RECEPTOR AGONISTS β€” 2026–2027 Edition

Approximately 43 Pages | Practical Dosing, Clinical Cases & Landmark Trials

🎯 FROM GUIDELINES TO REAL CLINICAL PRACTICE!

Are you an Internal Medicine Specialist, Endocrinologist, Diabetologist, General Practitioner, or healthcare professional looking to master practical diabetes management, insulin therapy, obesity treatment, and modern GLP-1-based medications?

This exclusive bundle combines two comprehensive, evidence-informed medical eBooks designed to bridge the gap between theoretical knowledge and everyday clinical decision-making.

More than just textbooks β€” a structured, course-style learning experience built around real-world clinical practice.


πŸ“˜ BOOK 1: THE COMPLETE CLINICAL DIABETES CASEBOOK

2026–2027 Expanded Edition | 269 Pages | 61 Cases | 12 Sections

A Complete Case-Based Guide to Modern Diabetes Management

This expanded edition takes you step by step from patient presentation and diagnostic reasoning to treatment selection, insulin dose calculations, medication titration, monitoring, and follow-up.

WHAT WILL YOU LEARN?

🩸 1. TYPE 1 DIABETES MELLITUS

  • Newly diagnosed Type 1 Diabetes
  • Basal–bolus insulin initiation
  • Total Daily Dose (TDD) calculations
  • Insulin-to-Carbohydrate Ratio (ICR)
  • Insulin Sensitivity Factor (ISF)
  • Meal bolus and correction dose calculations
  • Honeymoon phase
  • Exercise-related hypoglycemia
  • Sick-day management and ketone monitoring
  • Continuous Glucose Monitoring (CGM)
  • Insulin pumps and Automated Insulin Delivery (AID)
  • Type 1 Diabetes with advanced CKD

πŸ’Š 2. TYPE 2 DIABETES MELLITUS

  • Initial monotherapy versus dual therapy
  • Rational triple therapy
  • Choosing the most appropriate glucose-lowering medications
  • Type 2 Diabetes with obesity
  • Diabetes with albuminuric CKD
  • Diabetes with cardiovascular disease
  • Basal insulin initiation and titration
  • Basal-plus and basal–bolus intensification
  • GLP-1-based treatment strategies
  • Hypoglycemia management in older adults
  • Dyslipidemia and cardiovascular risk reduction

🧬 3. OTHER TYPES OF DIABETES & EMERGENCIES

  • Latent Autoimmune Diabetes in Adults (LADA)
  • MODY 2, MODY 3, and HNF1B-MODY
  • Gestational Diabetes Mellitus (GDM)
  • Steroid-induced hyperglycemia
  • Pancreatogenic Diabetes (Type 3c)
  • Severe hypoglycemia
  • Diabetic Ketoacidosis (DKA)
  • Hyperosmolar Hyperglycemic State (HHS)
  • Euglycemic DKA associated with SGLT2 inhibitors

πŸ”¬ 4. WHEN HbA1c IS MISLEADING

Learn how to recognize falsely elevated or falsely reduced HbA1c in:

  • Iron-deficiency anemia
  • Hemolytic anemia
  • Hemoglobinopathies
  • Chronic kidney disease and dialysis
  • Recent blood transfusion
  • Pregnancy
  • Hypoalbuminemia

Includes practical diagnostic alternatives and an HbA1c discordance algorithm.

πŸ’§ 5. DIABETES INSIPIDUS

  • Central Diabetes Insipidus
  • Nephrogenic Diabetes Insipidus
  • Postoperative Diabetes Insipidus
  • Lithium-induced nephrogenic DI
  • Primary polydipsia versus DI
  • Post-traumatic Diabetes Insipidus

πŸ’‰ 6. ADVANCED INSULIN THERAPY

  • Once-weekly basal insulin
  • Emerging weekly insulin combinations
  • Practical prescribing considerations
  • Treatment selection and monitoring

πŸš€ 7. NEW DIABETES MEDICINES OF 2026

  • Orforglipron (Foundayo)
  • Oral semaglutide formulations
  • Wegovy pill
  • Ozempic pill
  • Newer oral glucose-lowering agents
  • Medication titration and switching
  • Renal and hepatic considerations
  • Drug interactions and safety monitoring

πŸ§ͺ 8. IMMUNOTHERAPY IN TYPE 1 DIABETES

  • Type 1 Diabetes staging
  • Autoantibody screening
  • Teplizumab (Tzield)
  • Beta-cell preservation
  • Emerging monoclonal antibody therapies
  • Clinical applications and future developments

🧫 9. BETA-CELL REPLACEMENT

  • Islet cell transplantation
  • Pancreas transplantation
  • Simultaneous pancreas–kidney transplantation
  • Patient selection and clinical considerations

🦢 10. DIABETIC NEUROPATHY β€” COMPLETE DRUG GUIDE

  • Painful diabetic peripheral neuropathy
  • Mirogabalin
  • Pregabalin and gabapentin
  • Duloxetine
  • Alternative and combination therapies
  • Renal and hepatic dose adjustments
  • Topical capsaicin
  • Autonomic neuropathy
  • Gastroparesis and orthostatic hypotension

πŸ₯— 11. NUTRITION, MEAL PLANNING & EXERCISE

  • Medical Nutrition Therapy
  • Carbohydrate counting
  • Seven-day meal plans
  • Nutrition in Type 1 and Type 2 Diabetes
  • Diabetes with CKD, heart failure, obesity, and MASLD
  • Ramadan considerations
  • Exercise prescriptions
  • Insulin adjustments during physical activity

πŸ’‘ 12. OPTOGENETICS & TAKE-HOME CLINICAL MESSAGES

  • Light-responsive insulin-producing cells
  • Experimental optogenetic technologies
  • Future approaches to Type 1 Diabetes
  • Experimental approaches to diabetic neuropathy
  • Insulin dosing quick-reference tables
  • Medication titration ladders
  • Renal and hepatic dose-adjustment tables
  • Emergency management principles
  • Practical clinical checklists

WHAT MAKES THIS BOOK DIFFERENT?

Each clinical case follows a structured approach:

Patient Presentation β†’ Investigations β†’ Diagnostic Reasoning β†’ Treatment Selection β†’ Dose Calculations β†’ Monitoring β†’ Follow-Up

With practical clinical pearls, medication tables, generic and trade names, and important safety considerations.


πŸ“— BOOK 2: THE COMPLETE PRACTICAL GUIDE TO GLP-1 RECEPTOR AGONISTS

Evidence-Based Clinical Handbook | 2026–2027 Edition

Approximately 43 Pages

A Focused Clinical Guide to Modern Diabetes and Obesity Pharmacotherapy

Explore the science, clinical applications, practical prescribing, and major evidence behind GLP-1-based therapies.

WHAT WILL YOU LEARN?

🧬 GLP-1 PHYSIOLOGY & MECHANISMS

  • GLP-1 receptor physiology
  • Glucose-dependent insulin secretion
  • Glucagon suppression
  • Appetite regulation
  • Gastric emptying
  • Weight reduction and metabolic effects

πŸ’Š COMPREHENSIVE MEDICATION GUIDE

  • Semaglutide
  • Liraglutide
  • Dulaglutide
  • Exenatide
  • Lixisenatide
  • Tirzepatide
  • Retatrutide (investigational)
  • Emerging incretin-based therapies

πŸ’‰ PRACTICAL PRESCRIBING & TITRATION

  • Choosing the appropriate GLP-1-based therapy
  • Starting doses
  • Dose escalation schedules
  • Switching between medications
  • Managing gastrointestinal adverse effects
  • Contraindications and precautions
  • Renal and hepatic considerations
  • Monitoring treatment response
  • Managing inadequate glycemic or weight response

βš–οΈ GLP-1 THERAPIES IN SPECIAL POPULATIONS

  • Type 2 Diabetes
  • Obesity and weight management
  • Cardiovascular disease
  • Chronic kidney disease
  • Metabolic liver disease
  • Patients receiving insulin
  • Complex patients with multiple comorbidities

πŸ“Š LANDMARK CLINICAL TRIALS

  • STEP
  • SUSTAIN
  • SELECT
  • FLOW
  • LEADER
  • REWIND
  • SURPASS
  • SURMOUNT

Learn how major clinical trials inform treatment decisions and the selection of incretin-based therapies.

🩺 PRACTICAL CLINICAL APPLICATIONS

  • Clinical case discussions
  • Practical medication tables
  • Common prescribing mistakes
  • Clinical pearls
  • Frequently asked questions
  • Follow-up and monitoring strategies

🌟 WHY GET BOTH BOOKS?

The Diabetes Casebook teaches you how to manage diabetes through practical clinical cases.

The GLP-1 Handbook helps you understand and prescribe modern incretin-based therapies.

Together, they cover:

βœ… Diabetes diagnosis and classification

βœ… Type 1 and Type 2 Diabetes management

βœ… Insulin calculations and dose adjustments

βœ… Monotherapy, dual therapy, and triple therapy

βœ… Diabetes emergencies and complications

βœ… GLP-1 and dual GIP/GLP-1 therapies

βœ… Obesity and metabolic disease management

βœ… Cardiovascular and renal considerations

βœ… Medication titration and monitoring

βœ… Landmark clinical trials

βœ… Emerging diabetes treatments

βœ… Evidence-informed clinical decision-making


πŸ‘¨β€βš•οΈ WHO IS THIS BUNDLE FOR?

  • Internal Medicine Residents and Specialists
  • Endocrinologists and Diabetologists
  • General Practitioners
  • Family Medicine Physicians
  • Clinical Nutrition Professionals
  • Physicians preparing for postgraduate examinations
  • Healthcare professionals interested in diabetes, obesity, and metabolic medicine

πŸ“¦ WHAT WILL YOU RECEIVE?

πŸ“˜ Book 1: The Complete Clinical Diabetes Casebook β€” 269 Pages

πŸ“— Book 2: The Complete Practical Guide to GLP-1 Receptor Agonists β€” Approximately 43 Pages

πŸ“š TOTAL: APPROXIMATELY 312 PAGES

πŸ“₯ Format: Two Digital PDF eBooks

🌍 Language: English

πŸ“… Edition: 2026–2027

✍️ Author: Dr. Abdullah Aboelkheir

Internal Medicine Specialist

Master's Degree in Internal Medicine β€” Al-Azhar University


πŸš€ TWO BOOKS. ONE COMPLETE CLINICAL LEARNING EXPERIENCE!

From understanding diabetes to making practical treatment decisions and exploring modern GLP-1-based therapies.

Whether you're managing newly diagnosed diabetes, calculating insulin doses, selecting advanced glucose-lowering medications, or treating patients with obesity, cardiovascular disease, and chronic kidney disease, this bundle is designed to help you connect clinical evidence with real-world practice.

πŸ“˜ Learn the principles.

🩺 Understand the clinical cases.

πŸ’Š Master the practical treatment approach.

🎯 FROM GUIDELINES TO PRACTICE!

πŸ”₯ GET BOTH MEDICAL eBOOKS TOGETHER IN ONE EXCLUSIVE DIGITAL BUNDLE!


You will get the following files:
  • PDF (1MB)
  • PDF (4MB)